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K. Bolla and J. Rignani 1979). Chronic exposure to a mixture of organic and inorganic lead is also related to reduced performance in tasks of executive/psychomotor function, manual dexterity, memory, and learning (Bolla, Schwartz, Stewart, Rignani, Agnew, & Ford, 1995; Schwartz, Bolla, Stewart, Ford, Agnew, & Frumkin, 1993) .
Few reports have described the natural history of neuropsychological functioning in lead exposed workers in a clinical setting. Workers seen in this context are usually involved with a variety of legal and labor/management issues which negatively impact their sense of well-being.
Long-term follow-up of this self-selected group of workers might provide invaluable information to the treating clinician who follows and treats them. For example, it is not uncommon for patients with past lead exposure to complain of deterioration in physical and mental functioning years after the cessation of exposure. This phenomenon has also been reported in patients with traumatic brain injury and has been attributed to psychosocial factors (Putnam, Millis, & Adams, 1996) . Therefore, it is of interest to know the course of symptoms and of the results of neuropsychological tests in order to determine if subjective symptoms correlate with objective measures of cognitive functioning.
Moreover, it is important to assess if the specific characteristics of workers impact their clinical status.
This case series describes the clinical course of neuropsychological functioning (physical, cognitive, and affective) in a group of self-selected workers who were chronically exposed to a mixture of organic and inorganic lead. An attempt was also made to determine if the clinical course of specific subgroups of workers could be predicted from measures of lead exposure, personality traits/affective state or demographic characteristics, as collected during an initial testing session in March 1990.
METHODS

Clinical Population
The participants in the current report were 23 lead exposed males employed by an organolead (tetraethyl lead -TEL) manufacturing facility in the eastern United States. In 1990, 222 mixed inorganic and organic lead exposed workers in the plant underwent neuropsychological testing as part of a cross-sectional study of the neuropsychological effects of organic and inorganic lead exposure. At the conclusion of the study, all workers received feedback on their performance. Subnormal performance was defined by the neuropsychologist (K.B.) as performance below the 5th percentile of the entire group of 222 workers, on 4 or more tests out of a total of 22 tests, in at least 2 different cognitive domains. From the original 222 workers, subnormal performance on the neuropsychological performance tests was identified for 20/222 (9%) of the workers. These workers were encouraged to seek follow-up evaluation. Also, all workers, regardless of test results, were offered the opportunity for follow-up evaluation. Twenty-three of the 222 workers requested a follow-up neuropsychological evaluation. In March 1990, 6 of these 23 workers demonstrated subnormal performance while 17/23 workers demonstrated normal performance.
Job Titles and Lead Exposure
Job titles held by the workers included 13 mechanics, 6 operators, 2 pipe-coverers/fitters, 1 welder, and 1 electrician. Details of exposure in the plant have been previously reported (Schwartz et al., 1993 ). An important temporal trend in exposures in the plant was apparent in blood lead and urine lead data. From September 1989 to May 1990, exposure decreased in the area due to new engineering controls, improved housekeeping, new work practices, and mandatory personal protective equipment use. Mean blood lead of the workers at the plant dropped from 30 mcg/dl in 1989 to 22 mcg/dl in 1990. No data was available on plant blood levels after 1990. However, blood levels at the time of retest were obtained on 12/23 workers.
Symptoms
Symptoms were recorded using the structured Scandinavian Questionnaire Sixteen, (416; Hogstedt, Hane, & Axelson, 1980) . The 416 measures the number of symptoms complaints that are commonly associated with significant exposure to neurotoxicants (e.g., attention/ concentration problems, poor memory, depression). A factor analysis performed on the entire sample of 222 workers resulted in the 416 total score loading with the MMPIHypochondriasis, Depression, and Psychasthenia scales on Factor 1. None of the neuropsychological test scores loaded on Factor 1. Therefore, the total score on the Q16 appears to be most strongly associated with affective status. The Q16 follows a yes-no format. The 416 was administered to all 23 workers during the initial testing session. Unfortunately, because the follow-up evaluation was performed for clinical rather that research purposes, only 13/23 of the workers were administered the 416 during the follow-up visit.
Psychometric Investigation
During the first testing session, workers were tested in private rooms at a site near the plant. During the second testing session, workers were tested at a University Medical Center. The neuropsychological test battery was identical for both testing sessions. The battery was designed to target five domains of cognitive performance: verbal intelligence, verbal memory and learning, visual memory and learning, executive/psychomotor functions, and manual dexterity/motor (Table 1) . Examiner-administered and computer-administered tests were employed. All examiners were trained by the neuropsychologist (K.B.).
Psychological Profile
The Minnesota Multiphasic Personality Inventory (MMPI) was used to measure the personality traits and affective state of the workers in March 1990. In order to reduce the duration of the testing session, the workers were asked to complete the 566-item MMPI at home and return it in a postage paid envelope. Only five of the workers returned the MMPI at follow-up. Therefore, MMPI changes between the two testing sessions cannot be presented in this case series.
RESULTS
The demographics of the 23 workers and the entire group of 222 workers are presented in Table 2 . Comparison of the demographic and exposure characteristics of the two groups revealed that the 23 workers evaluated in a follow-up session were representative of the entire group of 222 workers. However, at baseline, they reported slightly more symptom complaints on the 416. Of the 23 males who were clinically evaluated, 22 were Caucasian and one was African American. Current blood levels at the time of re-test were available on 12/23 of the workers. A decline was observed in current blood levels from lifetime weighted and lifetime peak blood levels.
Due to the high variability and small sample size, the data were first analyzed as ordered data using the Wilcoxon sign-rank test and Spearman rank correlations and then as frequency data using Chi-square analyses with Yates correction and Odds Ratios. To determine if the direction and magnitude of change in performance was significant between the two testing 'Wechsler, 1981 . 2Rey, 1964 . 3Cassito et al., 1990 . 4Kapur & Butters, 1977 . 'Letz, 1990 . 6Reitan, 1977 . 7Agnew et al., 1988 . 'Hogstedt et al., 1980 . AMilan Automated Neurobehavioral System (formerly the World Health Organization test battery). BNeurobehavioral Evaluation System. sessions, the Wilcoxon sign-rank test was performed on the difference of each of the individual neuropsychological test measures (Table 3) . A significant improvement in performance was found on only l/23 of the tests, the Serial Digit Learning test. Near significant improvements 0) < 0.06) were observed in the WAIS-R Vocabulary and WAIS-R Block Design. Significant declines in performance were found on the CPT, Simple Visual Reaction Time and Finger Tapping for the dominant hand. The change in performance on the Eye-Hand Coordination was nearly significant (p < 0.06). There was also a significant increase in the total number of CNS and PNS symptoms reported on the 416. However, this finding is based only on the 13 workers who completed the Q16 twice.
In order to transform the data into frequency data, a change in neuropsychological performance was defined in three categories: worse, same, and better. A worker was placed into the worse category if their level of performance decreased between test sessions 1 and 2 by equal to or greater than one SD for that individual test (based on the performance of the entire 222 lead exposed group). Likewise, a worker was placed in the better category if performance increased by equal to or greater than one SD. If the change in test score fell between -1 and + 1 SD, the worker was placed in the "same" category. We then calculated the number or frequency of workers who fell into each of the three categories ( Table 3 ). The greatest percentage of workers fell into the "same" category on all of the neuropsychological tests. The 416 was the only measure that showed more workers falling into the "worse" category than any other category. Ten of the 13 workers who completed the 416 twice reported more total symptoms during the second evaluation.
In order to determine if we could predict a change in performance at follow-up from individual demographic and exposure characteristics, we examined the following variables as possible determinants of change: age, verbal intelligence (WAIS-R vocabulary test), duration of exposure, lifetime-weighted average mean blood lead level, lifetime peak blood lead level, the number of reported symptoms on the 416 at baseline (March 1990) , the number of symptoms that were report on the Hysteria, Depression, and Hypochondriasis scales of the MMPI at baseline, the length of time between testing sessions, and results of the first test session (subnormal or normal). For example, a worker with a greater duration of exposure might show a change in neuropsychological functioning that differs from that of a worker with a shorter duration of exposure. Contingency tables were used to examine the association between individual demographic characteristics (e.g., age, duration of exposure) and the direction of change in performance. The median value for each of the predictor variables was used to divide workers into two groups (high vs. low, normal vs. subnormal) for each of the predictor variables. These median values are presented in Table 2 . For the MMPI variables, a T score of 65 was used as the dividing point. Chi-square analysis with a Yates correction for small cell size was then performed and odds ratios were calculated. None of the Yates corrected chi-squares or odds ratios were significant for any of the predictor variables. Therefore, in this sample of workers, individual characteristics did not predict if, or how, neuropsychological functioning would change over time. In the 13 workers who were given the 416 twice, more symptoms were reported on the follow-up 416 as compared to the initial March 1990 416 (Table 4 ). This was true for 13 out of the 16 symptoms evaluated by the Q 16. Increases in total symptom complaints were associated with decrements in neuropsychological performance. The change in total score on the Q16 was correlated with change in performance on visual retention (r = -0.78, p < O.Ol), 44 (11) 6 (2) 12 (2) 9 (3) 13 (2) 24 (4) 9 (1) 16 (6) 14 (5) 15 17 (6) 377 33 (7) 251 (38) 30 (10) 72 (28) 13 (2) 13 (2) 30 (7) 54 (7) 50 (6) 9 (3) 4 ( .Ol+ *Values are percentage of workers; change in performance is Session 2 score minus Session 1 score; categories are: worse = a decline in performance of equal to or greater than one standard deviation based on the performance of the entire group of 222 lead workers for that individual test; same = a change in test score between -1 and 1 SD; better = an increase in performance of equal to or greater than 1 SD. Wilcoxon sign-rank test, arrows (-4) represent the direction of significant change from Baseline testing. **Values represent means (SD). digit symbol substitution (r = -0.48, p < 0.05), simple visual reaction time (I = 0.77, p < 0.01) and finger tapping-non-dominant hand (r = -0.47, p < 0.05). The more symptoms reported, the greater the decline in performance.
DISCUSSION
Our present observations suggest that follow-up neuropsychological testing contains considerable inter-individual variability, which renders difficult any interpretation and generalizability of the results of follow-up. In general, it appears that little change in neuropsychological functioning occurs over time in this population. However, when changes do occur, they do so in tests of psychomotor/motor speed. In the 13 workers who were given the 416 twice, 10 reported more total symptoms at follow-up. In addition, for the group, a change in symptoms was associated with psychomotor/motor slowing. For workers who showed an improvement or deterioration, no predictors for these changes could be identified.
Before continuing further discussion, we must address some methodological issues. Although this report deviates from a traditional case series because we attempt to make inferences based on clinical observations, this approach is justified by the dearth of knowledge about the clinical course of chemically exposed workers. We also acknowledge selection bias in our group of workers. Although 6 of the 23 workers who returned for follow-up testing did so as a result of subnormal test findings at the initial testing, the other 17 workers had tested within the normal limits. These workers elected to undergo a complete medical and neuropsychological evaluation to rule out any health effects that may have been linked to their employment in a lead manufacturing plant. This type of self-selection bias is problematic for an epidemiologic study but not for a report of clinical findings in a group of patients. In fact, all patients who seek medical and neuropsychological evaluation are self-selected.
Nine of the 17 (53%) workers with normal evaluations in March 1990, had subnormal evaluations at follow-up [a normal -subnormal determination was based on the clinical judgement of the neuropsychologist (K.B.) as outlined earlier]. The mandatory use of personal protection as well as better plant hygiene contributed to a decline in plant lead levels over the course of the test-retest interval. In addition, in the 12 workers who had blood lead measured at retest, blood lead levels declined from a mean lifetime average of 29 mcg/dl to 19 mcg/dl. Therefore, because it is unlikely that acute lead exposure itself was responsible for declines in neuropsychological performance or increased symptoms (which generally reflect a recent exposure), we are proposing that psychosocial factors are probably responsible for the observed changes. Expectations by workers that exposure to lead has adversely affected their central and peripheral nervous systems results in enhanced awareness of normal bodily sensations. This normal physiological activity is misinterpreted as abnormal physical, cog: nitive, and affective symptoms. The cause of these symptoms is then misattributed to exposure to lead. Other factors which may have been contributory to the workers loss of "feelings of well-being" during this test-retest period were changes in labor and management practices in addition to various legal issues. While this interpretation is speculative, our current data and past work support this idea. For example, all 13 workers who were measured for symptom frequency twice, reported increases in the frequency of affective, cognitive, and physical symptoms. Moreover, more workers reported feeling depressed at follow-up then I30 K. Bolla and J. Rignani during the initial session. This idea is further supported by the presence of significant associations between increases in the total number of symptoms and decrements on tests that assess visual memory as well as psychomotor/motor speed. This association between increased total symptoms on the Q 16 and decreased psychomotor performance could be related to either an increase in anxiety and depression or worsening of peripheral nervous system functions especially because the greatest increase in symptoms were reported on questions related to anxiety and depression and peripheral nerve disorders. We believe that decreased psychomotor/motor speed is not related to peripheral nervous system dysfunction because six of the eight workers that reported more peripheral nerve symptoms at retest had no evidence of peripheral nerve damage on nerve conduction velocity studies, although all six workers reported depression. Also, one of the workers with abnormal nerve conduction velocities reported no symptoms on items 15 and 16 (peripheral nerve symptoms). In addition, total 416 score is closely associated with affective and symptom status (i.e., similar Factor 1 loading with MMPI Hypochondriasis, Depression, and Psychasthenia scales). Thus, we suggest that increased depression could account for the observed decreased psychomotor performance, and, through increased somatization, increased endorsement of Q16 items. Previous investigations also found decrements in these specific cognitive domains in groups of patients with affective disorders who characteristically suffer from high levels of anxiety and depression (Miller, 1975) . More specifically, increased reports of memory difficulties in our workers were not associated with declines in performance on objective memory testing. This finding replicates our previous findings in healthy older adults (Bolla, Lindgren, Bonaccorsy, & Bleecker, 1991) . We found that memory complaints in older adults were related more to depressed mood than to performance on objective memory tests. In another study, we found no objective evidence of memory difficulties in 5 1% of patients referred for formal memory testing due to memory complaints. However their mood was significantly depressed (Bolla-Wilson & Bleecker, 1986) . Larrabee and Levin (1986) also demonstrated that ratings of decline in memory function were related to affective status rather than to performance on a traditional memory test (e.g. Selective Reminding).
None of the variables that we thought a priori might determine the clinical course of our workers (i.e. age, verbal intelligence, baseline -March 1990 evaluation results, blood lead levels, the number of initial symptoms reported, or elevations on the three subscales of the MMPI) were found to be associated with systematic changes in neuropsychological performance. Neither lifetime weighted average blood lead levels or lifetime peak blood lead levels were associated with performance changes. This lack of association may be due to the relatively low blood lead levels (mean blood leads 4 to 43 mcg/dl and peak level less that 60 mcg/dl). The possibility that blood lead does not provide a very sensitive measure of organolead exposure should also be taken into consideration (Schwartz et al., 1994) .
In some workers, the development of physical symptoms and cognitive declines at follow-up may be related to anxiety or depression. These affective symptoms may develop because workers acquire a heightened awareness of normal bodily sensations that they then misinterpret as abnormal symptoms. In turn, these symptoms are misattributed to exposure to lead. Therefore, it appears that early education, symptom management, knowledge of a worker's perception of and possible psychological reactions to, working in a chemically laden environment are important therapeutic methods of intervention. If intervention is initiated as early as possible after identification of exposure, a decline in physical, cognitive and emotional functioning may be avoidable.
